awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34973750-3C7E79C2-64EF-414A-A9EF-569102070D64
Q34973750-3C7E79C2-64EF-414A-A9EF-569102070D64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-3C7E79C2-64EF-414A-A9EF-569102070D64
Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents
P2860
Q34973750-3C7E79C2-64EF-414A-A9EF-569102070D64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-3C7E79C2-64EF-414A-A9EF-569102070D64
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a824c796b2dbfd78ecfc3a91a09bfb8e11027052
P2860
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.